throbber
200
`
`PROTEIN ACY LA TIONS/DEACYLA TIO NS
`
`[11)
`
`UT Assay Procedure. The mixture of 5 µ,l of UT sample is allowed to
`incubate for a few minutes at 26°, then 5 µ,I of E. coli PnA (0 .4 unit/ml) is
`added to initiate the uridylylation reaction. After a suitable incubation
`period, 70 µ,I of the deadenyJylation reaction mixture preequilibrated at
`26° is added to determine the amount of P1m formed. After 5 min of
`incubation, I ml of the y-glutamyltransferase mixture is added, and after
`another 4 min, the reaction is stopped by adding 1 ml of the stop mixture.
`The resulting solution is centrifuged, and its absorbance at 540 nm is
`recorded. The control tube is prepared with the UT sample by a similar
`procedure as the sample tube with the exception that the UT assay mix(cid:173)
`ture is substituted by the UT assay blank mixture.
`The procedures described above can be used to measure Puo and UT
`activity in S. typhimurium, 43 P. putida, 44 and K . aero genes. 45 This is
`possible because P1m from those organisms stimulates the deadenylyla(cid:173)
`tion reaction catalyzed by E.coli ATd and because E. coli PnA is uridylyl(cid:173)
`ated by UT activities from various organisms.
`
`[11] Determination and Occurrence of
`Tyrosine O-Sulf ate in Proteins
`By WIELAND 8. HUTTNER
`
`The term ' ' protein sulfa ti on' ' describes the modification of proteins by
`covalent attachment of sulfate. One can distinguish between two principal
`types of protein sulfation. The first type is the covalent linkage of sulfate
`to amino acid residues of proteins, i.e., the primary modification of the
`polypeptide chain itself. Only one amino acid, tyrosine, has so far been
`shown to undergo this modification. The second type is the covalent
`linkage of sulfate to carbohydrate moieties of glycoproteins and pro(cid:173)
`teoglycans. In structural terms this type of sulfation is a secondary modifi(cid:173)
`cation of the polypeptide chain, the primary one being protein glycosyla(cid:173)
`tion. Both sulfated tyrosine and sulfated carbohydrate residues can
`apparently occur in the same protein.
`The sulfate linked to tyrosine is present as an 0 4-sulfate ester. Such a
`tyrosine 0 4-sulfate residue was first identified in 1954 in bovine fibrino(cid:173)
`peptide B. 1 In the 28 years following this discovery, the presence of
`
`1 F. R . Bettelheim, J . Am. Chem. S oc. 76, 2838 (1954).
`
`METHODS IN ENZYMOLOG Y. VO L. 107
`
`Copyright © 1984 by Acade mic Press. Inc.
`All righ1s of reproduc1io n in any form reserved.
`
`I ISBN ~ 12- '82000'<
`
`-200-
`
`
`
`
`MAIA Exhibit 1022
`MAIA V. BRACCO
`IPR PETITION
`
`

`

`(11]
`
`TYROSINE SULFATION OF PROTEINS
`
`201
`
`tyrosine sulfate, initiaJly believed to be restricted to fibrinogens and fi(cid:173)
`brins, 2 was detected in a few biological peptides, such as gastrin II,3
`phyllokinin,4 caerulein,5 cholecystokinin,6 and Leu-enkephalin,7 as well
`as in the small polypeptide hirudin.8 Except for these peptides (and their
`precursors), however, the occurrence of tyrosine sulfate in proteins re(cid:173)
`mained virtually unnoticed until recently. In fact, when proteins were
`found to be sulfated, this was, with a single exception,9 generally taken to
`be indicative of the presence of sulfated carbohydrate residues.
`In a more recent study , 10 the possible widespread occurrence of tyro(cid:173)
`sine sulfate in proteins was investigated. Tyrosine sulfate was detected in
`proteins from a wide variety of vertebrate tissues and cell cultures in
`many molecular weight ranges. Since this recognition of tyrosine sulfation
`as a widespread modification of proteins, at least 10 specific tyrosine(cid:173)
`sulfated proteins have been newly identified and partially characterized.
`These are (1) the four major sulfated proteins of a rat pheochromocytoma
`cell line (PC12), designated as pl 13, p105 , p86, and p84, which were also
`found to be phosphorylated on serine11 ; (2) the major soluble sulfated
`protein of the rat brain, designated as pl 20, which was found to be devel(cid:173)
`opmentally regulated 12 ; (3) three prominent sulfated proteins of the chick
`retina, designated as pl 10, p102, and p93, which were found to move by
`fast axonal transport down the optic nerve12, (4) an acidic secretory pro(cid:173)
`tein of the bovine anterior pituitary, 13 originally described by Rosa and
`Zanini 14
`; (5) immunoglobulin G of some hybridoma cell lines 15 ; and
`(6) vitellogenin of Drosophila. 15
`
`2 F. R. Jevons, Biochem. J. 89,62 1 (1963).
`3 H. Gregory, P. M. Hardy , D. S. Jones , G. W. Kenner, and R. C. Sheppard, Nature
`(L ondon) 204, 931 (1964).
`4 A. Anastasi, G. Bertaccini. and V. Erspamer, Br. J. Pharmacol. Chemother. 21, 479
`(1966).
`5 A. Anastasi, V. Erspamer. and R. Endean, Arch. Biochem. Biophys. 125, 57 (1968).
`6 V. Mutt and J.E. Jorpes, Eur. J. Biochem. 6, 156 (1968).
`7 C. D. Unsworth , J. Hughes, and J. S. Morley, Nature (London) 29S, 5 19 ( 1982).
`8 T. E. Petersen. H . R. Roberts, L. Sollrup-Jensen, S . Magnusson, and D. Bagdy, in
`"Protides of Biological Fluids " (H. Peeters, ed.), Vol. 23, p. 145. Pergamon. Oxford,
`1976.
`9 G. Scheele, D. Bartelt, and.W. Bieger, Gastroenterolol?Y 80,461 (198 1).
`10 W. B. Huttner, Nature (London) 299, 273 (1982).
`11 R. W. H. Lee and W. 8. Huttner, J . Biol. Chem. 258, 11 326 ( 1983); R. W. H. Lee.
`A . Hille, and W. B. Huttner, unpublished observations.
`12 S. B. Por and W. 8 . H uttner, manuscripts in preparation.
`13 P. Rosa. G. Fumagalli, A. Zanini. and W. B. Huttner, manuscript submitted for publi(cid:173)
`cation.
`14 P. Rosa and A. Zanini , Mot. Cell. Endocrinol. 24, 181 ( 198 1).
`'5 P. A. Baeuerle and W. 8. Huttner. manuscripts submitted for publication.
`
`-201-
`
`
`
`
`

`

`202
`
`PROTEIN ACYLATIONS/ DEACYLATIONS
`
`[11)
`
`The role of tyrosine sulfation in the function of these proteins is the
`subject of current investigations. A possible common denominator may
`be the observation that aH polypeptides so far known to contain tyrosine
`sulfate either are secretory proteins or show properties consistent with
`them being secretory proteins. It is therefore possible that tyrosine sulfa(cid:173)
`tion is involved in the processing, sorting, or functioning of some secre(cid:173)
`tory proteins. In the case of the known proteins, tyrosine sulfation may
`occur during their passage through the Golgi complex; it appears to be
`only slowly reversible or even irreversible. 11
`It is, however, too early to draw general conclusions about the subcel(cid:173)
`lular compartmentation and the degree of reversibility of tyrosine sulfa(cid:173)
`tion. The proteins mentioned above are only some of the tyrosine-sulfated
`proteins existing in the respective cell systems, and only a few celI sys(cid:173)
`tems have so far been studied. Clearly, many more tyrosine-sulfated pro(cid:173)
`teins are yet to be discovered, and many more known proteins need to be
`tested for the presence of tyrosine sulfate. Hopefully, by learning more
`about tyrosine-sulfated proteins, we will achieve an understanding of the
`biological role(s) of this modification. In the following sections, some of
`the current procedures used to detect tyrosine-sulfated proteins and to
`study this modification are described. 16
`
`Chemical Synthesis and Properties of Tyrosine Sulfate
`
`Synthesis. L-Tyrosine O 4-sulfate is synthesized according to the
`method of Reitz et al. 17 by the reaction of L-tyrosine with concentrated
`sulfuric acid at low temperature. After the reaction, the sulfuric acid is
`neutralized and precipitated by addition of barium hydroxide. The tyro(cid:173)
`sine sulfate is freed from unreacted tyrosine and Ba2+ by passage through
`a cation exchanger. The final product may contain variable amounts of
`tyrosine 3'-sulfonate, which can be distinguished from tyrosine sulfate by
`its slightly different electrophoretic mobility at pH 3.5, its distinct ultravi(cid:173)
`olet absorption spectrum, and its stability to acid at elevated temperature.
`The appearance of tyrosine 3 '-sulfonate can be minimized (less than 1 % of
`the tyrosine sulfate) by limiting the reaction time of tyrosine with sulfuric
`acid to 15 min and by keeping the reaction temperature low (between
`
`16 For recent overviews of sulfation , the reader is referred to two excellent books: G . J .
`Mulder, " Sulfation of Drugs and Related Compounds," CRC Press, Boca Raton, Florida.
`1981 ; G. J. Mulder, J. Caldwell, G. M. J. Van Kempen , and R. J. Vonk, " Sulfate Metabo(cid:173)
`lism and Sulfate Conjugation," Taylor & Francis, London, 1982.
`17 H. C. Reitz, R. E . Ferrel, H. Fraenkel-Conrat, and H . S. Olcott, J. A m. Chem. Soc. 68,
`!024 (1946).
`
`-202-
`
`
`
`
`

`

`fll]
`
`TYROSINE SULFATION OF PROTEINS
`
`203
`
`-25 and -10°). Tyrosine O4-[35S]sulfate is synthesized by the same proto(cid:173)
`col, using [35S]H2SO4.
`Properties. One of the most remarkable properties of tyrosine sulfate
`is the lability of the ester bond in acid and its stability in alkali. More than
`95% of the ester is hydrolyzed after 5 min in 1 M HCI at 100°, making it
`impossible to detect tyrosine sulfate after acid hydrolysis of proteins. The
`acid lability of the ester presumably explains why tyrosine sulfate is not
`observed when peptides known to contain this modified amino acid are
`sequenced by chemical methods. Fortunately, more than 90% of the ester
`remains after 24 hr in 0.2 M Ba(OH)2 at 110°, making alkaline hydrolysis
`the method of choice to detect tyrosine sulfate in proteins. Tyrosine sul(cid:173)
`fate (Ba2+, K ~, or Na+ salt) is stable in neutral aqueous solution at 4° for
`weeks, and standard solutions can be kept frozen at -20° for at least a
`year. The ultraviolet absorption spectrum of tyrosine sulfate is different
`from that of tyrosine, showing a peak at 260.5 nm with a molar extinction
`coefficient of 283 (pH 7 .0). 18
`
`Detection of Tyrosine Sulfate in Proteins
`
`This chapter focuses on the detection of tyrosine-sulfated proteins and
`on the determination of tyrosine sulfate by methods that are based on
`labeling proteins with 35SO4 • This approach has several advantages over
`the chemical determination of tyrosine sulfate in unlabeled proteins. It
`can be much more easily used to search for tyrosine-sulfated proteins and
`is considerably more sensitive and therefore requires less protein material
`for analysis. An immunological approach to detect tyrosine-sulfated pro(cid:173)
`teins has been developed in our laboratory .18 Antisera were raised against
`a synthetic antigen containing a large number of tyrosine sulfate residues,
`and antibodies were purified from the antisera by affinity chromatogra(cid:173)
`phy. These antibodies appeared to recognize tyrosine sulfate-containing
`proteins in "Western" blots and in solid-phase radioimmunoassay. The
`general usefulness of these antibodies to screen for, immunoprecipitate,
`or purify tyrosine-sulfated proteins is currently being tested.
`The standard method to detect tyrosine sulfate in proteins involves
`four main steps described in Sections 1-4 below: ( I) in vivo labeling of
`tissues in situ or of tissue explants, tissue slices, and ce1ls in culture with
`inorganic [35S]sulfate; (2) separation of proteins by polyacrylamide gel
`electrophoresis (PAGE); (3) elution from gels and hydrolysis of individual
`35SOrlabeled proteins; (4) separation of tyrosine [35S]sulfate by thin-layer
`electrophoresis. Major modifications of and additions to the standard
`
`18 P. A. Baeuerle, Diploma Thesis , University of Konstanz, 1983.
`
`-203-
`
`
`
`
`

`

`204
`
`PROTEIN ACYLA TIONS/DEACYLA TIO NS
`
`[11]
`
`steps are described in separate paragraphs at the end of each section. A
`general scheme of the various procedures is shown in Fig. I.
`
`1. Labeling with 35 SO4
`When whole animals are labeled with 35S04 , one should bear in mind
`that the isotope becomes distributed throughout the body and that its
`specific activity is reduced by the endogenous unlabeled sulfate. Thus, in
`order to achieve sufficient 35S04 incorporation into proteins of the tissue
`of interest, relatively large quantities of 35S04 of high specific activity
`(> 900 Ci/mmol) should be used. For example, a single intraperitoneal
`injection of 20 mCi of 35S04 into a 100-g rat was sufficient for the detection
`of sulfated proteins in various tissues and in the plasma 18 hr after the
`injection by SOS-PAGE and fluorography of the gels for 30 hr. 10 More
`efficient labeling is found if the 35S04 is administered to the tissue of
`
`[35S}SULFATE LABELING OF TISSUES OR CELLS
`
`Tissue / cell
`homogeno te or
`subtroclion
`
`15S] PAJ'S labeling
`
`[
`
`OE NATURATION OF PROIEINS IN SOS OR UREA
`
`Jmmunoprec,p,I olion
`Acetone prec1pilol1an
`
`SOS - PAGE OR 20 - PAGE
`
`ARG OR F6
`
`ALKALINE HYDROLYSIS OR EXIENSIVE PRONASE DIGESTION
`
`10 OR 20 ! HIN - LAYER ELECTROPHORESIS . ARG OR FG
`
`Fro. I. Schematic outline of the sequence of procedures used to detect tyrosine sulfate in
`proteins. Thick arrows indicate the sequence of the standard method; thin arrows indicate
`modifications and additions. ARG, autoradiography; FG, fluorograph y.
`
`-204-
`
`
`
`
`

`

`[11]
`
`TYROSINE SULFATION OF PROTEINS
`
`205
`
`interest directly. For example, sulfated proteins could easily be detected
`in the chick retina or the rat brain 1 hr after injection of 2 mCi of 35SO4 into
`the chick eye or the third ventricle of the rat brain, respectively, by SDS(cid:173)
`PAGE and fluorography of the gels for 15 hr.12
`Mammalian tissues are not capable of reducing 35SO4 for the synthesis
`of [35S]methionine and L35S]cysteine. Nevertheless, one encounters
`[35S]methionine and [35S]cysteine incorporation into proteins after label(cid:173)
`ing whole animals with 35SO4 . This is presumably due to the synthesis of
`[35S]methionine and [35S]cysteine by bacteria present in the gastrointesti(cid:173)
`nal tract of the animals and can be prevented by using germfree animals.
`Although this phenomenon makes the interpretation of fluorograms of
`SDS-polyacrylamide gels less straightforward, it poses no problem for
`the identification of tyrosine [35S]sulfate in protein hydrolysates, using
`thin-layer electrophoresis (see Section 4).
`When tissue ex plants and cells are labeled in culture with 35SO4 , effi(cid:173)
`cient 35SO4 incorporation into proteins is achieved by adding carrier-free
`35SO4 to sulfate-free medium. Many culture systems use medium supple(cid:173)
`mented with some sort of serum, and the presence of low concentrations
`of unlabeled sulfate (up to about 10-4 M) , as is the case when sulfate-free
`medium supplemented with undialyzed serum is used , still allows satis(cid:173)
`factory radioactive sulfate incorporation into proteins. In this case, the
`reduction in the specific activity of 35SO4 is presumably compensated to
`some extent by the increase in cellular sulfate uptake. The advantage
`of using the isotope at high specific activity should be balanced against
`the potential disadvantage that may result from the use of dialyzed serum
`and from starving cells of sulfate. It is therefore recommended to as(cid:173)
`certain that the use of sulfate-free medium and (when serum is required
`for the culture) the use of dialyzed serum during 35SO4 labeling does not
`reduce the viability of the cells under investigation. In particular, the
`capacity for protein synthesis should not be impaired, since protein syn(cid:173)
`thesis appears to be required for suifate incorporation into some pro(cid:173)
`teins .11 In our experience, the use of carrier-free sulfate (about 0.5 mCi/ml
`final concentration) in sulfate-free medium supplemented with a reduced
`concentration (1-5%) of undialyzed serum has resulted in very efficient
`incorporation of radioactive sulfate into PCl 2 cell proteins after labeling
`periods of up to 18 hr.
`Since incorporation of 35SO4 into proteins may occur at both tyrosine
`residues and carbohydrate residues, it can be informative to pe1form
`35SO4 labeling in the absence and in the presence of inhibitors of N(cid:173)
`glycosylation, e.g. , tunicamycin. For example, in the slime mold Dictyo(cid:173)
`stelium discoideum, protein sulfation was virtually abolished by tunicamy(cid:173)
`cin, and analysis of sulfated proteins for the presence of tyrosine sulfate
`
`-205-
`
`
`
`
`

`

`206
`
`PROTEIN ACY LA TIONS/ DEACYLA TIO NS
`
`[11]
`
`gave essentially negative results. 19 In PC12 cells, the four proteins desig(cid:173)
`nated pl13, pI05, p86, and p84, known to contain most of the incorpo(cid:173)
`rated sulfate as tyrosine sulfate, 11 were labeled similarly with 35SO4 in the
`absence and in the presence of tunicamycin.
`Labeling with 3'-Phosphoadenosine 5'-Phospho[35SJsu[fate (PAPS).
`The study of tyrosine sulfation of proteins has been extended to cell-free
`systems. ll Using the radiolabeled "activated sulfate" [35S]PAPS as sul(cid:173)
`fate donor, transfer of 35SO4 to tyrosine residues of endogenous protein
`acceptors, catalyzed by an endogenous tyrosylprotein sulfotransferase,
`can be observed in cell lysates and some subcellular fractions. At present,
`the labeling efficiency of proteins in cell lysates is less than that obtained
`in intact cells, for several reasons. (1) The specific activity of commercially
`available [35S]PAPS is relatively low (~2 Ci/mmol), compared with that
`of inorganic [35S]sulfate (>900 Ci/mmol). (2) The proportion of the pro(cid:173)
`tein of interest that is in the unsulfated form, and thus a substrate for
`labeling, may be small at any given time point including that of cell Jysis,
`whereas in intact ceJls ongoing protein synthesis continuously supplies
`unsulfated substrate protein. There can be little doubt, however, that, as
`the components of cell-free tyrosine sulfation of proteins are elucidated,
`sulfation of defined proteins by tyrosylprotein sulfotransferase will be(cid:173)
`come more efficient, and the results obtained will increasingly contribute
`to our understanding of the role of tyrosine sulfation.
`
`5SO4-Labeled Proteins
`2. Separation of 3
`After labeling of tissues or cell cultures with 35SO4 , reactions are
`terminated and proteins are solubilized for separation on polyacrylamide
`gels. For these purposes, the use of SDS together with boiling at neutral
`pH appears to be the most suitable method, since it fulfills all the follow(cid:173)
`ing requirements.
`
`1. Rapid inactivation of enzymes. Although at present little is known
`about the possible regulation of the sulfation of specific proteins by extra(cid:173)
`cellular and intracellular signals, only the preservation of the in vivo state
`of protein suJfation by rapid enzyme inactivation may allow the observa(cid:173)
`tion of such regulatory phenomena.
`2. Avoidance of low pH. The tyrosine sulfate ester is labile in acidic
`conditions at elevated temperatures. Although the ester bond may be
`stable in acidic conditions in the cold, it appears safer to avoid low pH
`
`19 J. Stadler, G. Gerisch, G. Bauer, C. Suchanek, and W. 8 . Huttner, EMBO J. 2, 1137
`(1983).
`
`-206-
`
`
`
`
`

`

`[11]
`
`TYROSINE SULFATION OF PROTEINS
`
`207
`
`whenever possible. It is for this reason that we avoid the use of trichlo(cid:173)
`roacetic acid for terminating sulfation reactions.
`3. Complete solubilization of proteins. Proteins solubilized in SDS
`can be subjected to phenol extraction, immunoprecipitation, SDS-PAGE
`and, after acetone precipitation, two-dimensional PAGE (see Fig. I).
`
`An SOS-containing, neutral solution that we have found to be suitable
`for most purposes is the sample buffer according to Laemmli, 20 referred to
`as "stop solution." Cells attached to culture dishes and cell pellets are
`directly dissolved in stop solution [3% (w/v) SDS, 10% (w/v) glycerol,
`3.3% (v/v) 2-mercaptoethanol, a trace of bromophenol blue, and 62.5 mM
`Tris-HCl, pH 6.8), whereas cells in suspension are mixed with 0.5 volume
`of three times concentrated stop solution, followed in both cases by im(cid:173)
`mediate boiling of the samples for 3-5 min. Tissues are rapidly frozen in
`liquid nitrogen, crushed into a fine powder under liquid nitrogen, and then
`dissolved in stop solution followed by boiling.
`After 35S04 labeling, tissues and cells may be subjected to subcellular
`fractionation, and the subcellular fractions of interest can then be dis(cid:173)
`solved in stop solution. It should be borne in mind, however, that rapid
`regulatory phenomena in the sulfation of proteins, should they exist,
`might be lost during the fractionation process.
`In an attempt specifically to remove sulfated carbohydrate residues
`from proteins aner 35S04 labeling and at the same time preserve tyrosine
`sulfate residues, we have subjected PC12 cell proteins, known to contain
`tyrosine sulfate, 11 to treatment with anhydrous hydrogen fluoride accord(cid:173)
`ing to Mort and Lamport. 21 In our experience, however, all the sulfate
`was removed from these proteins by this treatment. We have not used
`enzymatic deglycosylation to distinguish between the presence of sulfated
`carbohydrate residues and tyrosine sulfate residues, but this may be. use(cid:173)
`ful in some cases.
`If specific proteins arc to be subjected to immunoprecipitation prior to
`electrophoresis, cells and tissues can be dissolved in a neutral buffer
`without 2-mercaptoethanol containing 1-3% (w/v) SOS followed by boil(cid:173)
`ing. The SOS is then diluted by addition of the nonionic detergent Nonidet
`P-40, and immunoprecipitation is pe1formed according to standard proce(cid:173)
`dures. 22 Alternatively, cells can be dissolved in RIPA buffer and subjected
`to immunoprecipitation as described.23 Immunoprecipitates can be dis-
`
`20 U. K. Laemmli , Nature (London) 227, 680 (1970).
`21 A. J. Mort and D. T . A. Lamport, Anal. Biochem. 82, 289 (1977).
`22 S. E. Goelz, E . J. Nestler, B. Chehrazi , and P Greengard , Proc. Natl. Acad. Sci. U.S .A.
`78, 2130 (1981).
`23 8. M. Sefton, K. Beemon, and T. Hunter, .I. Virol. 28,957 (1978).
`
`-207-
`
`
`
`
`

`

`208
`
`PROTEIN ACYLATIONS/DEACYLA TIONS
`
`[ 11]
`
`solved in stop solution (for SOS-PAGE) or in O'Farrell lysis buffer24 (for
`two-dimensional PAGE).
`Cells and tissues dissolved in stop solution can be subjected to any of
`the following protocols.
`
`1. A phenol extraction protocol as described in Procedure I, designed
`to separate the proteins from sulfated glycosaminoglycans, foJiowed by
`PAGE (see below). This procedure is similar to that introduced by Hunter
`and Sefton25 for the study of tyrosine phosphorylation of proteins, and
`used in that case to separate proteins from nucleic acids and phospho]i(cid:173)
`pids. The effect of phenol extraction is illustrated in Fig. 2.
`2. SDS-PAGE according to Laemmli. 20
`3. Two-dimensional PAGE using either isoelectric focusing or non(cid:173)
`equilibrium pH gradient electrophoresis in the first dimension, as de(cid:173)
`scribed by O'Farrell. 24 For two-dimensional PAGE, samples in stop solu(cid:173)
`tion are mixed with 5 volumes of acetone, kept at -20° until precipitation
`occurs, and centrifuged. The pellets are washed in 80% (v/v) acetone,
`dried, and dissolved in O'Farrell lysis buffer containing 5% (w/v) Nonidet
`P-40. Alternatively, cells attached to culture dishes or cell pellets can als~
`be directly dissolved into lysis buffer. In our experience, both types of
`sample preparation give rise to similar separations upon two-dimensional
`PAGE.
`
`Procedure I. Phenol Extraction of Sulfated Proteins
`1. Dissolve sample, e.g. , 35S04-labeled cells in culture, in stop solu(cid:173)
`tion (0.5-5 mg of protein per mi1liliter of stop solution). Boil immediately
`for 3-5 min.
`2. Unless otherwise indicated, the following steps are performed at
`room temperature. Prepare phenol solution: dissolve phenol in an equal
`amount (w/v) of HEN buffer (50 mM HEPES-NaOH, pH 7.4; 5 mM
`EDTA; 100 mM NaCl), mix vigorously for 5 min, let stand or centrifuge
`until phases are separated. The lower phase is HEN buffer-saturated
`phenol (referred to as phenol solution), the upper phase is phenol-satu(cid:173)
`rated HEN buffer (referred to as HEN solution).
`3. Mix the sample with an equal volume of phenol solution, vortex
`vigorously for at least 30 sec, centrifuge for IO min at 15,000 rpm in a
`Sorvall SS34 rotor.
`
`24 P.H. O'Farrell, J. Biol. Chem. 250, 4007 (1975); P. Z. O'Farrell, H. M. Goodman, and P.
`H. O'Farrcll, Cell 12, 1133 (1977).
`25 T. Hunter and B. M. Sefton, Proc. Natl. Acad. Sci. U.S.A. 77, 13 11 ( 1980).
`
`-208-
`
`
`
`
`

`

`[11]
`
`TYROSINE SULFATION OF PROTEINS
`
`209
`
`-
`
`+
`
`FIG. 2. Autoradiograms showing the effect of the phenol extraction protocol described in
`Procedure I. PC 12 cells were labeled with 35SO4 and subjected to SOS-PAGE, without (-)
`or with ( +) prior phenol extraction. Arrows indicate major tyrosine-sulfated proteins. 11
`Some of the proteins can be better seen after phenol extraction.
`
`4. Collect the aqueous (upper) phase. If flocculent material at the
`interface is present, avoid disturbing it. Keep phenol (lower) phase plus
`interface.
`5. Mix the aqueous phase with an equal volume of phenol solution~
`vortex and centrifuge as before. Discard the aqueous phase; keep the
`phenol phase plus interface.
`6. Pool the phenol phases plus interfaces from first and second extrac(cid:173)
`tion ; reextract 1-3 times with equal volume of HEN solution. Discard
`aqueous phases each time. The efficiency of extraction can be monitored
`by spotting aliquots of the aqueous phases on filter paper and observing
`the decline in radioactivity with a portable ,B-radiation monitor or by
`liquid scintillation counting.
`
`-209-
`
`
`
`
`

`

`210
`
`PROTEIN ACYLATIONS/ DEACYLATIONS
`
`(11]
`
`7. Add five volumes of cold ( - 20°) ethanol to final phenol phase plus
`intetface. If necessary, transfer to larger centrifuge tube. Mix well and
`keep at - 20° until precipitation has occurred (2 hr or longer). Centrifuge
`for IO min at 10,000 g in a Sorvall SS34 rotor. Discard the supernatant.
`Wash the precipitate once with chloroform-methanol (2: 1) and collect it
`by centrifugation as above. Allow the precipitate to dry.
`8. Dissolve the precipitate in stop solution (for SOS-PAGE), in lysis
`buffer (for two-dimensional PAGE), or in 0.2 M Ba(OHh (for alkaline
`hydrolysis and determination of tyrosine sulfate, see Procedure Ill).
`
`After electrophoresis, gels are fixed and (if desired) stained and de(cid:173)
`stained by conventional procedures, using acetic acid rather than trichlo(cid:173)
`roacetic acid. Fixed gels can also be subjected to an acid treatment that is
`described in a subsection at the end of this section. For the detection of
`35SOdabeled proteins, gels are prepared for fluorography, dried, and
`fluorographed at -70°. We use exclusively the sodium salicylate method26
`for fluorography, primarily because the salicylate is water-soluble and can
`therefore easily be removed from gels after fluorography. This renders the
`proteins present in the gel suitable for further biochemical analysis, e.g.,
`peptide mapping by limited proteolysis, tryptic fingerprinting, tyrosine
`sulfate analysis, (see below). If the labeling of proteins is sufficiently
`intense, the salicy)ate treatment of gels can be omitted, and the dried gels
`are subjected to autoradiography at room temperature. The X-ray film
`used in our laboratory for autoradiography and fluorography is Kodak
`XAR-5.
`An alternative, rapid procedure to obtain an autoradiogram after
`SDS-PAGE or two-dimensional PAGE is to transfer the proteins from
`the gel onto nitrocellulose filter paper using the " Western" blotting tech(cid:173)
`nique. After the transfer, the nitrocellulose fiJter paper is either air-dried
`and autoradiographed or is dipped in 20% PPO in toluene, dried, and
`fluorographed at - 70°. This procedure has two advantages.
`
`1. The time needed for autoradiography after transfer to nitrocellulose
`filter paper is shorter than with dried polyacrylamide gels.
`2. The sulfated material that is often found as a diffuse smear in the
`high molecular weight regions of SDS-polyacrylamide gels (presumably
`sulfated proteoglycans or glycosaminoglycans) does not appear to trans(cid:173)
`fer very well from the gel to the nitrocellulose filter paper. Thus, autora(cid:173)
`diograms obtained after transfer of 35SO4-]abeled proteins to nitrocellu(cid:173)
`lose filter paper tend to be "cleaner" than those of the corresponding gels
`
`26 J. P. Chamberlain, Anal. Biochem. 98, 132 (1979).
`
`-210-
`
`
`
`
`

`

`[11]
`
`TYROSINE SULFATION OF PROTEINS
`
`21 I
`
`and can be compared to autoradiograms obtained after SDS-P AGE of
`phenol-extracted samples (Fig. 2).
`35S04-labeled proteins separated in polyacrylamide gels can be used
`for hydrolysis (see Section 3 below) and tyrosine sulfate analysis (Section
`4). If desired (see Fig. 1), individual sulfated protein bands can first be
`subjected to limited proteolysis in SDS and peptide mapping in SDS
`polyacrylamide gels,27 or to extensive proteolysis and two-dimensional
`fingerprinting by thin-layer electrophoresis/chromatography. In these
`cases, the resulting peptide fragments can be used for hydrolysis and
`tyrosine sulfate analysis.
`HCl Treatment of Proteins in Polyacrylamide Gels. The details of the
`method are described in Procedure II, below. The rationale of this treat(cid:173)
`ment is to screen, among the variety of sulfated proteins present in a
`sample, for those likely to contain tyrosine sulfate. Since the tyrosine
`sulfate ester is remarkably acid-labile and appears to be hydrolyzed faster
`than most carbohydrate sulfate esters, a short acid treatment will lead to a
`preferential loss of sulfate from tyrosine residues. When such an acid
`treatment is performed on 35S04-labeled proteins fixed in polyacrylamide
`gels, the resulting autoradiographic pattern may show some labeled bands
`that disappear quite specifically after the acid treatment (i.e., their reduc(cid:173)
`tion is greater than the small overall reduction in labeled bands). These
`specifically acid-sensitive bands may contain a large proportion of their
`sulfate label as tyrosine sulfate. In the examples illustrated in Fig. 3, there
`appears to be a good correlation between the acid sensitivity of bands and
`their tyrosine sulfate content.
`It may, however, be too early to assume generally that a correlation
`between these two parameters will be found in every case because one
`cannot rule out false-positive and false-negative results. Possible explana(cid:173)
`tions for false-positive acid se1isitivity of bands incJude the following. (1)
`Sulfated residues other than tyrosine sulfate, e.g., certain carbohydrate
`sulfate esters, may exist that are as acid-sensitive as tyrosine sulfate
`ester. (2) The acid treatment may lead to hydrolysis of some peptide
`bonds. This may result in the formation of peptide fragments small
`enough to remain no longer fixed in the gel but to diffuse out. If sulfated
`residues other than tyrosine sulfate, e.g., sulfated carbohydrates, were
`located in such peptide fragments , an acid treatment-induced loss of 35S04
`label would be observed without the actual hydrolysis of a tyrosine sulfate
`ester. False-negative acid sensitivity, i.e., the apparent lack of acid sensi-
`
`27 D. W. Cleveland, S. G. Fischer, M. W. Kirschner, and U. K. Laemmli , J. Biol. Chem.
`252, 1102 (1977).
`
`-211-
`
`
`
`
`

`

`212
`
`PROTEIN ACYLA TIONS/DEACYLATIONS
`
`[11]
`
`A
`
`B
`
`C
`
`--
`
`F10. 3. Autoradiograms showing the effect of the HCI treatment described in Procedure
`II on proteins separated by SOS-PAGE: (A) proteins of rat pheochromocytoma cells
`(PC12), labeled with [35S]methionine; (B) same, labeled with [.l5S)sulfate; (C) proteins of
`Dictyostelium discoideum, labeled with (35S)sulfate. Compared with the control (- ), the HCl
`treatment ( +) does not lead to a loss of protein from the gel (A). The HCI treatment
`markedly reduces the 11S04 label of PC 12 cell proteins known to contain tyrosine sulfate 11
`(arrows) (B), but only slightly the 35S04 label of D. discoideum proteins known to contain
`sulfate on carbohydrate residues 19 (C).
`
`tivity of bands despite the presence of tyrosine sulfate, may also be ob(cid:173)
`served. For example, if a glycoprotein contained 10 sulfated carbohydrate
`residues and I tyrosine sulfate residue, the acid treatment-induced spe(cid:173)
`cific Joss of 35SO4 label of about 10% would not readily be noticed upon
`comparative autoradiography. Despite these considerations, the acid
`treatment of gels is a useful and simple tool in searching for tyrosine(cid:173)
`sulfated proteins, particularly when this method is combined with the
`
`-212-
`
`
`
`
`

`

`[11]
`
`TYROSINE SULFATlON OF PROTEINS
`
`213
`
`procedure to determine tyrosine sulfate in individual proteins obtained
`from polyacrylamide gels (Section

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket